Total Funding
70
60
Total FundingGrant raised
Growth Score
-8 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
27946
Hemanext is a medical technology company offering a blood processing, storage, and transfusion solution.
- Andrew Dunham: CEOPast Role: Baxter Healthcare, Vice President of Research and Development
Eric Newman: Chief Financial Officer
About the Company
Hemanext is a medical technology company offering a blood processing, storage, and transfusion solution. Hemanext enhances the effectiveness, safety, affordability, and efficacy of transfusion therapy. Hemanext helps the community of transfusion medicine in its initiatives to save lives and enhance patient outcomes.
